Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

Chinese scientists have developed a breakthrough process that significantly improves the efficiency and environmental ...

A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in ...

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

Long-acting muscarinic antagonists, as add-on therapy to inhaled corticosteroids, improve lung function parameters and reduce ...

Hepatitis C virus (HCV) infection is highly associated with the development of metabolic dysfunction-associated steatotic ...

The Ivalice Chronicles will include two versions of the game — the classic original (which includes the War of the Lions translation), and a fresh new version with full-blown voice acting ...

This agreement grants Lilly exclusive, worldwide rights to research, develop, manufacture, and commercialize long-acting incretin ... dual GIP and GLP-1 receptor agonists, triple GIP, glucagon ...

Eli Lilly joins up with Camurus to make long ... agonists. Lilly’s Phase III candidate retatrutide is a triple agonist. The deal also features an option to include amylin receptor agonists. Products ...

Eli Lilly is counting on Camurus and its long-acting delivery technology to help ... collaboration include dual GIP and GLP-1 receptor agonists, triple GIP, glucagon and GLP-1 receptor agonists ...

This image provided by the Fermi National Accelerator Laboratory shows the ring-shaped track that scientists used to study tiny particles called muons, July 20, 2023 in Batavia, Ill. (Ryan ...

The Company is also developing long-acting injectable and oral small molecule APJ agonists. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary ...